Score: 0 / 0 answered
Progress: 0 of 1007 qs
time elap: 00:00
Question 1: Which pharmacogenomic marker is associated with an increased risk of severe neutropenia in patients receiving 6-mercaptopurine?
Subject: Pharmacogenomics and Personalized Medicine in Pharmacy Examining Board of Canada - PEBC
Difficulty: Hard